Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia‐bearing mice
- 7 January 2013
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 160 (6), 766-778
- https://doi.org/10.1111/bjh.12196
Abstract
Current treatment of leukemia focuses on increasing chemotherapy efficacy. Mesenchymal stromal cells (MSCs) have been proposed for carrying and delivery drugs to improve cancer cells-specific killing. Recently, we have shown that MSCs loaded with the anti-cancer drug Paclitaxel (PTX), acquire a potent anti-tumor activity. To expand these findings, we here investigate the effect of human MSCs (hMSCs) and mouse SR4987 loaded with PTX (hMSCsPTX and SR4987PTX) on Molt-4 and L1210, two Leukemia cell (LC) lines of human and mouse origin respectively. We found that SR4987PTX and hMSCsPTX had a strong anti-LC activity. HMSCsPTX co-injected with Molt-4 or intra-tumor injected into an established subcute Molt-4 nodules strongly inhibited growth and angiogenesis. In syngenic BDF1 mice-bearing L1210, the intraperitoneal administration of SR4987PTX doubled mice survival time. In vitro, both hMSCs and hMSCsPTX released chemotactic factors, bound and formed rosette with LCs. By ultrastructural analysis of rosette, hMSCsPTX showed no morphological alterations while the attached LCs were apoptotic and necrotic. Finally, MSCs and MSCsPTX released molecules that reduced LCs adhesion to microvascular endothelium (hMECs) and down-modulated the adhesion molecules ICAM-1 and VCAM-1 on hMECs. We conclude that, besides conventional chemotherapy, MSCsPTX could be a new therapeutic approach to treat Leukemia in humansKeywords
Funding Information
- AIRC (Associazione Italiana Ricerca Cancro) Project (AIRC IG-9062)
- Fondazione Banco del Monte di Lombardia
This publication has 43 references indexed in Scilit:
- Mesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer TherapyPLOS ONE, 2011
- Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potentialVascular Cell, 2011
- Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?The International Journal of Cell Cloning, 2010
- Tumor cell behaviour modulation by mesenchymal stromal cellsMolecular Cancer, 2010
- Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cellsJournal of Experimental & Clinical Cancer Research, 2009
- A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicityBlood, 2009
- β1 Integrin Adhesion Enhances IL-6–Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and ProliferationCancer Research, 2009
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2008
- Pancreas developing markers expressed on human mononucleated umbilical cord blood cellsBiochemical and Biophysical Research Communications, 2004
- Childhood cancer mortality in Europe, 1955–1995European Journal of Cancer, 2001